GSK: UK-based British pharma GSK pauses diversity work citing Trump orders

London-based FTSE 100 firm is reviewing its policies saying it is obliged to comply because US government is its No1 customerBritish pharma company GSK has paused diversity activities for UK workers, claiming that it is obliged to do so in response to executive orders by the US president, Donald Trump.The FTSE 100 company has also scrubbed references to "diversity" from its website. GSK is led by Emma Walmsley, one of the few women to lead a FTSE 100 company. Continue reading...